TABLE 2.

Clinical Outcomes Stratified by VerifyNow and WBA

	Nonresponsive Platelets on VerifyNow, n = 100	Responsive Platelets on VerifyNow, n = 95	p
Mortality at 24 h	1 (1.0)	1 (1.1)	1.00
In-hospital mortality	3 (3.0)	6 (6.3)	0.324
Hemorrhage progression	26 (27.1)	24 (26.1)	0.877
ICU admission	34 (34.3)	38 (40)	0.415
ICU stay for those admitted (d)	2.5 (1–5)	3 (1–7)	0.482
Total hospital stay (d)	3 (2–8)	3.2 (2–7)	0.818
D/c other than home	46 (46.5)	38 (40)	0.387

	Nonresponsive Platelets on WBA, n = 145	Responsive Platelets on WBA, n = 49
Mortality at 24 h	3 (2.1)	0 (0)	0.572
In-hospital mortality	7 (4.9)	3 (6.1)	0.716
Hemorrhage progression	40 (28.4)	8 (17.4)	0.139
ICU admission	52 (36.1)	18 (36.7)	1.00
ICU stay for those admitted (d)	3 (1–6)	3 (1–9)	0.203
Total hospital stay (d)	3 (2–7.3)	3 (2–5.6)	0.638
D/c other than home	65 (45.1)	21 (42.9)	0.868

Data are reported as median (IQR), or percentage.

This table includes patients on aspirin, clopidogrel and patients on no antiplatelet medication. Patients with nonresponsive platelets on either VNA or VNP (or both) are counted as nonresponsive. Patients with responsive platelets on both VNA and VNP are counted as responsive. Similarly, patients with nonresponsive WBA with AA or WBA with ADP result are counted as nonresponsive while patients with responsive platelets on both WBA with AA or WBA with ADP are counted as responsive.

D/c, discharge.